Mitsubishi Tanabe Cuts Ties with Four-year Generics Subsidiary, But Sales Goals Remain

Mitsubishi Tanabe sold all shares of its Choseido Pharmaceutical subsidiary after not meeting expectations, and must now reassess its generics strategy.